Ge Long Hui A P P·2025-09-17 07:48Core Viewpoint - Zhongjin Securities report indicates that new Fengming achieved a net profit attributable to shareholders of 709 million yuan in the first half of the year, representing a year-on-year increase of 17.28% [1] Financial Performance - In Q2, the net profit attributable to shareholders was 403 million yuan, showing a year-on-year growth of 22.24% and a quarter-on-quarter increase of 31.44% [1] - The average selling price of major products decreased year-on-year, while PTA sales volume growth contributed to overall revenue increase [1] Production Capacity and Revenue - By mid-2025, the company's PTA production capacity is expected to reach 7.7 million tons [1] - In the first half of the year, PTA revenue was 4.652 billion yuan, compared to 1.18 billion yuan in the same period last year, with sales volume of 1.0879 million tons, up from 226,500 tons year-on-year [1] Strategic Initiatives - The company is actively exploring the industrialization path of bio-based materials [1] - In July 2025, the company announced plans to invest 100 million yuan in Hefei Lif Biotechnology Co., acquiring a 7.0175% stake post-investment [1] - Lif Biotechnology is one of the earliest teams globally to research furan-based materials, and its FDCA technology is expected to enable the company to explore high-end bio-based fibers and green packaging [1]